| View |
|
DRP-12308-01
|
DL-Alpha-Tocopherol (Vitamin E)
|
None
|
400 I.U.
|
Softgel Capsule
|
Vitamin
|
Titanium Technologies (India) Pvt. Ltd
|
India
|
CLIDP Conversion
|
13 December 2023
|
16 June 2027
|
| View |
|
DRP-12319-02
|
Carboplatin
|
Carbowind 450
|
10 mg/mL (450 mg/45 mL)
|
Solution for IV Infusion
|
Antineoplastic
|
Admac Lifesciences
|
India
|
CLIDP Conversion
|
26 November 2023
|
29 July 2028
|
| View |
|
DRP-12412-07
|
Losartan Potassium
|
Pillarlife
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Antagonist
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
09 December 2023
|
03 August 2025
|
| View |
|
DRP-12528-01
|
Celecoxib
|
Coxibral
|
200 mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Ratnatris Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
26 November 2023
|
26 August 2027
|
| View |
|
DRP-12541-01
|
Dobutamine (as hydrochloride)
|
Dobucy
|
50 mg/mL
|
Solution for IV Infusion
|
Adrenergic and Dopaminergic agent
|
Farbe Firma Pvt. Ltd
|
India
|
CLIDP Conversion
|
03 December 2023
|
30 August 2027
|
| View |
|
DRP-12591-03
|
Cefixime (as trihydrate)
|
Zelpis-100
|
100 mg/5 mL (20 mg/mL)
|
Powder for Oral Suspension
|
Antibacterial (Cephalosporin)
|
Globela Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
14 December 2023
|
19 September 2027
|
| View |
|
DRP-12592-02
|
Cefixime (as trihydrate)
|
Q Xef
|
20 mg / mL
|
Powder for Oral Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
Globela Laboratories Private Limited
|
India
|
CLIDP Conversion
|
03 December 2023
|
19 September 2027
|
| View |
|
DRP-12594-02
|
Carbocisteine + Zinc
|
None
|
500mg/5mg (equivalent to 13.725mg Zinc Sulfate Monohydrate)
|
Film Coated Tablet
|
Mucolytic/Mineral
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
09 December 2023
|
09 September 2027
|
| View |
|
DRP-12601-05
|
Febuxostat
|
Emdirix
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Sunrise International Labs Limited
|
India
|
CLIDP Conversion
|
13 December 2023
|
14 September 2027
|
| View |
|
DRP-12601-06
|
Febuxostat
|
Atenugen
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Sunrise International Labs Limited
|
India
|
CLIDP Conversion
|
09 December 2023
|
14 September 2027
|
| View |
|
DRP-12671-04
|
Ketorolac trometamol
|
Ketorolem
|
30 mg / mL
|
Solution for Injection (I.M./I.V.)
|
Non-Steroidal Anti-inflammatory and Anti-rheumatic Product (Acetic Acid Derivative)
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
03 December 2023
|
21 September 2027
|
| View |
|
DRP-12737-03
|
Telmisartan + Amlodipine (as besilate)
|
Amplify 80/5
|
80 mg /5 mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
03 December 2023
|
30 September 2027
|
| View |
|
DRP-12854-01
|
Cefuroxime (as axetil)
|
Zuri-250
|
250 mg / 5 mL
|
Powder for Oral Suspension
|
Antibacterial (Cephalosporin)
|
Globela Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
13 December 2023
|
28 October 2027
|
| View |
|
DRP-12879-01
|
Ketoanalogues + Essential Amino Acids
|
Analou
|
630 mg
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
22 November 2023
|
25 October 2027
|
| View |
|
DRP-12924-01
|
Co-Amoxiclav
|
Goclav-125
|
156.25 mg/5 mL
|
Powder for Oral Suspension (Orange Flavor)
|
Antibacterial (Penicillin + Beta-Lactamase Inhibitor)
|
Yeluri Formulations Pvt Ltd.
|
India
|
CLIDP Conversion
|
03 December 2023
|
22 November 2027
|
| View |
|
DRP-12973-03
|
Ciprofloxacin (as lactate)
|
Ciprovue
|
2 mg/mL (200 mg/100 mL)
|
Solution for IV Infusion
|
Antibacterial (Fluoroquinolone)
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
03 December 2023
|
11 November 2027
|
| View |
|
DRP-13059-04
|
Telmisartan + Amlodipine (as besilate)
|
Telmiget Duo
|
40 mg/ 5 mg
|
Tablet
|
Angiotensin II Receptor Blockers (ARBs) and Calcium Channel Blocker
|
Titan Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
13 November 2023
|
24 November 2027
|
| View |
|
DRP-13089-03
|
Telmisartan + Amlodipine (as besilate)
|
Telmiget Duo
|
80 mg/ 10 mg
|
Tablet
|
Angiotensin II Receptor Blockers (ARBs) and Calcium Channel Blocker
|
Titan Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
13 December 2023
|
28 November 2027
|
| View |
|
DRP-13142-03
|
Telmisartan + Amlodipine (as besilate)
|
Telmiget Duo
|
80 mg/ 5 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB) and Calcium Channel Blocker
|
Titan Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
13 December 2023
|
07 December 2027
|
| View |
|
DRP-13144-01
|
Norepinephrine (as bitartrate)
|
Noriter
|
1 mg/mL (4 mg/4 mL)
|
Solution for Injection (IV)
|
Adrenergic/Dopaminergic Agent
|
Farbe Firma Pvt. Ltd.
|
India
|
CLIDP Conversion
|
03 December 2023
|
07 December 2027
|